Skip to main content

Fernando Moreno Flores

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Bioquímic/a Clínic/a
Clinical Laboratories
Cross-departmental services
Fernando Moreno Flores

Fernando Moreno Flores

Fernando Moreno Flores

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Bioquímic/a Clínic/a
Clinical Laboratories
Cross-departmental services

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Yesilkoy Filiz

Yesilkoy Filiz

Senior researcher
Microbiology
Read more
Sonia Galindo Maycas

Sonia Galindo Maycas

Read more
Marylin Riveiro Vilaboa

Marylin Riveiro Vilaboa

Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Carmen Rodriguez Fernandez

Carmen Rodriguez Fernandez

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.